Transforming growth factor-α in carcinogen-induced F344 rat hepatic foci

Toxicology and Applied Pharmacology

Volumn 140, Issue 1, 1996, Pages 131-145

  Steinmetz, Karen L ^a   Klaunig, James E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; TRANSFORMING GROWTH FACTOR ALPHA;

ADENOMA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA; CELL MEMBRANE; CONTROLLED STUDY; CYTOCHEMISTRY; DNA SYNTHESIS; EOSINOPHIL; LABELING INDEX; LIVER CARCINOGENESIS; LIVER CELL; LIVER HISTOLOGY; MALE; NONHUMAN; PHENOTYPE; RAT; STAINING;

ANIMALIA; RODENTIA;

EID: 0030245659     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0206     Document Type: Article

References (57)

1. Alison, M. R., Nasim, M. M., Anilkumar, T. V., and Saffar, C. E. (1993). Transforming growth factor-α immunoreactivity in a variety of epithelial tissues. Cell Prolif. 26, 449-460.
2. Bannasch, P. (1978). Sequential cellular alterations during hepatocarcinogenesis. In Rat Hepatic Neoplasia (P. W. Newberne and W. H. Butler, Eds.). MIT Press, Cambridge, MA.
3. Bauknecht, T., Angel, P., Kohler, M., Kommoss, F., Birmelin, G., Pfleiderer, A., and Wagner, E. (1993). Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Cancer 71(2), 419-429.
4. Blanc, P., Etienne, H., Daujat, M., Fabre, I., and Maurel, P. (1992). Mitotic responsiveness of culture adult human hepatocytes to epidermal growth factor, transforming growth factor a, and human serum. Gastroenterology 102, 1340-1350.
5. Burr, A. W., Carpenter, M. R., Hines, J. E., Gullick, W. J., and Burt, A. D. (1993). Intrahepatic distribution of transforming growth factor-alpha (TGFα) during liver regeneration following carbon tetrachloride-induced necrosis. J. Pathol. 170, 95-100.
6. Castilla, A., Prieto, J., and Fausto, N. (1991). Transforming growth factors β1 and α in chronic liver disease. N. Engl. J. Med. 324(14), 933-940.
7. Christensen, M. E., Therkildsen, M. H., Poulsen, S. S., and Bretlau, P. (1993). Transforming growth factor alpha and epidermal growth factor in laryngeal carcinomas demonstrated by immunohistochemistry. Acta Otolaryngol. (Stockholm) 113, 563-567.
8. Crawford, R. J., Penschow, J. D., Niall, H. D., and Coghlan, J. P. (1985). Mouse preproepidermal growth factor synthesis by the kidney and other tissues. Nature 313, 228-231.
9. Daoust, R., and Calamai, R. (1971). Hyperbasophilic foci as sites of neoplastic transformation hepatic parenchyma. Cancer Res. 31, 1290-1296.
10. Deguchi, J., Kawabata, T., Kondo, A., and Okada, S. (1993). Transforming growth factor-α expression of renal proximal tubules in Wistar rats treated with ferric and aluminum nitrilotriacetate. Jpn. J. Cancer Res. 84, 649-655.
11. DeLarco, J. E., and Todaro, G. J. (1978). Growth factors (SGFs) produced by murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA 75, 4001-4005.
12. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. (1987). Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res. 47, 707-712.
13. Evarts, R. P., Nakatsukasa, H., Marsden, E. R., Hu, Z., and Thorgeirsson, S. S. (1992). Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol. Carcinog. 5, 25-31.
14. Gabelman, B. M., and Emerman, J. T. (1992). Effects of estrogen, epidermal growth factor, and transforming growth factor-α on the growth of human breast epithelial cells in primary culture. Exp. Cell Res. 201, 113-118.
15. Harada, T., Maronpot, R. R., Morris, R. W., Stitzel, K. A., and Boorman G. A. (1989). Morphological and stereological characterization of hepatic foci of cellular alteration in control Fischer 344 rats. Toxicol. Pathol. 17(4, Part 1), 579-593.
16. Hsia, C. C., Axiotis, C. A., DiBisceglie, A. M., and Tabor, E. (1992). Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver. Cancer 70, 1049-1056.
17. Hu, Z., Fujio, K., Marsden, E. R., Thorgeirsson, S. S., and Evarts, R. P. (1994). Hepatic regeneration in vitamin A-deficient rats: Changes in the expression of transforming growth factor α/epidermal growth factor receptro and retinoic acid receptors α and β. Cell Growth Differ. 5, 503-608.
18. Ito, N., Tsuda, H., Tatematsu, M., et al. (1988). Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione-S-transferase placental form positive foci in rats - An approach for a new medium-term bioassy system. Carcinogenesis 9, 387-394.
19. Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., and Merline, G. T. (1990). TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61, 1137-1146.
20. Karasaki, S. (1976). Ultrastructural and cytochemical studies on hyperbasophilic foci with special reference to the demonstration of cell surface alterations in heptocarcinogenesis. Cancer Res. 36, 2567-2572.
21. Kaufmann, W. K., Zhang, Y., and Kaufman, D. G. (1992). Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms. Carcinogenesis 13(8), 1481-1483.
22. Lee, D. C., Rochford, R., Todaro, G. J., and Villarreal, L. P. (1985). Developmental expression of rat transforming growth factor-α mRNA. Mol. Cell. Biol. 5(12), 3644-3646.
23. Marsman, D. S., and Popp, J. A. (1994). Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis 15(1), 111-117.
24. Massagué, J. (1990). Transforming growth factor-α. J. Biol. Chem. 265(35), 21393-21396.
25. Masuhara, M., Katyal, S. L., Nakamura, T., and Shinozuka, H. (1992). Differential expression of hepatocyte growth factor, transforming growth factor-α, and transforming growth factor-β1 messenger RNAs in two experimental models of liver cell proliferation. Hepatology 16, 1241-1249.
26. Mead, J. E., and Fausto, N. (1989). Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. USA 86, 1558-1562.
27. Miller, R. T., Cattley, R. C., Marsman, D. S., Lyght, O., and Popp, J. A. (1995). TGFα is differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. Carcinogenesis 16(1), 77-82.
28. Moore, M. A., Nakagawa, K., Satoh, K., Ishikawa, T., and Sato, K. (1987). Single GST-P positive liver cells - Putative initiated hepatocytes. Carcinogenesis 8(3), 483-486.
29. Murakami, H., Sandersokn, N. D., Nagy, P., Marino, P. A., Merlino, G., and Thorgeirsson, S. S. (1993). Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor a in hepatic oncogenesis. Cancer Res. 53, 1819-1723.
30. Nasim, M. N., Thomas, D. M., Alison, M. R., and Filipe, M. I. (1992). Transforming growth factor α expression in normal gastric mucosa, intestinal metaplasia, dysplasia, and gastric carcinoma - An immunohistochemical study. Histopathology 20, 339-343.
31. Nettesheim, P., Ferriola, P. C., Robertson, A. T., Iwanaga, T., Steigerwalt, R., and Rundhaug, J. E. (1992). Abnormalities of growth factor systems in transformed airway epithelial cells. In Multistage Carcinogenesis (C. C. Harris et al., Eds.), pp. 171-181. CRC Press, Boca Raton, FL.
32. Olsen, P. S., Boesby, S., Kirkegaard, P., Therkelsen, K., Almdal, T., Poulsen, S. S., and Nexæ, E. (1988). Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 8(5), 992-996.
33. Perez-Tomás, R., Mayol, X., Culler, X., Dax Ruiz, C., and Domingo, J. (1992). Transforming growth factor-α expression in rat experimental hepatocarcinogenesis. Histol. Histopathol. 7, 457-462.
34. Pilot, H. C., Barsness, L., and Goldsworthy, T. (1978). Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature 271, 456-458.
35. Pritchard, D. J., and Butler, W. H. (1988a). The ultrastructural features of aflatoxin B1-induced lesions in the rat liver. Br. J. Exp. Pathol. 69, 793-804.
36. Pritchard, D. J., and Butler, W. H. (1988b). The lectin-bonding characteristics of aflatoxin B1 induced lesions in the rat liver. J. Pathol. 154, 269-276.
37. Rao, M. S., Lalwani, N. D., Scarpelli, D. G., and Reddy, J. K. (1982). The absence of γ-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643. Carcinogenesis 3, 1231-1233.
38. Russell, W. E., Dempsey, P. J., Sitaric, S., Peck, A. J., and Coffey, R. J. (1993). Transforming growth factor-α (TGFα) concentrations increase in regenerating rat liver: Evidence for a delayed accumulation of mature TGFα. Endocrinology 133(4), 1731-1738.
39. Sandgren, E. P., Luetteke, H. C., Palmiter, R. D., Brinster, R. L., and Lee, D. C. (1990). Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61, 1121-1135.
40. Sato, K., Kitahara, A., Satoh, K., Ishikawa, T., Tatematsu, M., and Ito, N. (1984). The placental form of glutahione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. Gann 75, 199-202.
41. Satoh, K., Hatayama, I., Tateoka, N., Tamai, K., Shimizu, T., Tatematsu, M., Ito, N., and Sato, K. (1989). Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis 10(11), 2107-2111.
42. Sauter, E. R., Coia, L. R., Eisenberg, B. L., and Hanks G. E. (1995). Transforming growth factor alpha expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapy. Int. J. Radiation Oncol. Biol. Phys. 31(3), 567-569.
43. Schaff, A., Hsia, C. C., Sarosi, I., and Tabor, E. (1994). Overexpression of transforming growth factor-α in hepatocellular carcinoma and focal nodular hyperplasia from European patients. Hum. Pathol. 25, 644-651.
44. Scherer, E., Hoffmann, M., Emmelot, P., and Friedrich-Freksa, M. (1972). Quantitative study on foci of altered liver cells induced in the rat by a single dose of diethylnitroamine and partial hepatectomy. JNCI 49(1), 93-106.
45. Shinozuka, H., Kubo, Y., Katyal, S., Coni, P., Ledda-Columbano, G., Columbano, A., and Nakamura, N. (1994). Roles of growth factors and of tumor necrosis factor-α on liver cell proliferation induced in rats by lead nitrate. Lab. Invest. 71(1), 35-41.
46. Squire, R. A., and Levitt, M. H. (1975). Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res. 35, 3214-3223.
47. Stewart, H. L., Williams, G., Keysser, C. H., Lombard, L. S., and Montali, R. J. (1980). Histologic typing of liver tumors of the rat. JNCI 64(1), 178-193.
48. Strömblad, S., and Andersson, G. (1993). The coupling between transforming growth factor-α and the epidermal growth factor receptor during rat liver regeneration. Exp. Cell Res. 204, 321-328.
49. Tanno, S., and Ogawa, K. (1994). Abundant TGFα precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis 15(4), 1689-1694.
50. Todaro, G. J., Fryling, C., and DeLarco, J. E. (1980). Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA 77, 5258-5262.
51. Tomiya, T., and Fujiwara, K. (1993). Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Hepatology 18(2), 304-308.
52. Umekita, Y., Enokizono, N., Sagara, Y., Kuriwaki, K., Takasaki, T., Yoshida, A., and Yoshida, H. (1992). Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-α) in human breast cancer: Their relationship to oestrogen receptor status, histollogical grade, mitotic index, and nodal status. Virchows Arch. A Pathol Anat. 420, 345-351.
53. Vaughan, T. J., Pascall, J. C., and Brown, K. D. (1992). Nucleotide sequence and tissue distribution of mouse transforming growth factor-α. Biochim. Biophys. Acta 1132, 322-324.
54. Watenabe, K., and Williams, G. M. (1978). Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: Evidence that foci are precursors of neoplasms and the the promoter acts on carcinogen-induced lesions. JNCI 51, 1311-1314.
55. Webber, E. M., FitzGerald, M. J., Brown, P. I., Bartlett, M. H., and Fausto, N. (1993). Transforming growth factor-α expression during liver regenration after partial hepatectomy and toxic injury and potential interactions between transforming growth factor-α and hepatocyte growth factor. Hepatology 18(6), 1422-1431.
56. Yamanaka, Y., Friess, H., Kobrin, M. S., Buchler, M., Beger, H. G., and Korc, M. (1993). Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res. 13, 565-570.
57. Yeh, Y-C., Tsai, J-F., Chuang, L-Y., Yeh, H-W., Tsai, J-H., Florine, D. L., and Tam, J. P. (1987). Elevation of transforming growth factor α and its relationship to the epidermal growth factor and α-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res. 47, 896-901.